Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nathwani

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Evidence for multiclonality in multicentric Kaposi's sarcomaP S Gill, Y C Tsai, A P Rao, et al.
Cancer Research|October 1, 1992
Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in the County of Los Angeles: preliminary resultsA M Levine, D Shibata, J Sullivan-Halley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphomaA Tulpule, M U Rarick, J Kolitz, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Evidence for multiclonality in multicentric Kaposi's sarcomaP S Gill, Y C Tsai, A P Rao, et al.
Cancer Research|October 1, 1992
Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in the County of Los Angeles: preliminary resultsA M Levine, D Shibata, J Sullivan-Halley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphomaA Tulpule, M U Rarick, J Kolitz, et al.
Pageof 2